{"generic":"Mumps Skin Test Antigen","drugs":["MSTA","Mumps Skin Test Antigen"],"mono":{"0":{"id":"8a0ws0","title":"Generic Names","mono":"Mumps Skin Test Antigen"},"1":{"id":"8a0ws1","title":"Dosing and Indications","sub":{"0":{"id":"8a0ws1b4","title":"Adult Dosing","mono":"<b>Cell-mediated immune reaction; Diagnosis:<\/b> 0.1 mL INTRADERMALLY on the forearm "},"3":{"id":"8a0ws1b7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Cell-mediated immune reaction; Diagnosis<br\/><b>Non-FDA Labeled Indications<\/b><br\/>Papillomatosis<br\/>"}}},"3":{"id":"8a0ws3","title":"Contraindications\/Warnings","sub":[{"id":"8a0ws3b9","title":"Contraindications","mono":"<ul><li>hypersensitivity to eggs\/egg products or inactive ingredients in the commercial product<\/li><li>hypersensitivity to thimerosal<\/li><\/ul>"},{"id":"8a0ws3b10","title":"Precautions","mono":"<ul><li>administration should be done in a location with facilities to manage acute hypersensitivity reactions<\/li><li>vial contains dry natural latex rubber<\/li><\/ul>"},{"id":"8a0ws3b11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},{"id":"8a0ws3b12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"8a0ws5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Dermatologic:<\/b>Skin reaction - finding, Local tenderness, pruritus<br\/><b>Serious<\/b><br\/><b>Immunologic:<\/b>Allergic reaction, acute (Severe)<br\/>"},"6":{"id":"8a0ws6","title":"Drug Name Info","sub":{"0":{"id":"8a0ws6b17","title":"US Trade Names","mono":"MSTA<br\/>"},"2":{"id":"8a0ws6b19","title":"Class","mono":"Immunological Diagnostic Agent<br\/>"},"3":{"id":"8a0ws6b20","title":"Regulatory Status","mono":"RX<br\/>"}}},"9":{"id":"8a0ws9","title":"Administration","mono":"<b>Intradermal<\/b><br\/><ul><li>shake well before withdrawing dose<\/li><li>inject on inner surface of forearm; evaluate injection site for reaction in 48 to 72 h<\/li><\/ul>"},"10":{"id":"8a0ws10","title":"Monitoring","mono":"skin test reaction; 48 to 72 hours following administration <br\/>"},"13":{"id":"8a0ws13","title":"Clinical Teaching","mono":"Instruct patient to return to healthcare professional 48 to 72 h after administration to have injection site assessed.<br\/>"}}}